SCHEMBL3833950

SCHEMBL3833950

CC(C)(C)OC(=O)NCCCOc1cccnc1[N+](C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.48
CA1 P00915 5/20 0.48
CA2 P00918 5/20 0.48
CA9 Q16790 5/20 0.48
CYP3A4 P08684 1/20 0.46
SCN9A Q15858 1/20 0.45
KDM4E B2RXH2 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
DRD2 P14416 4/20 0.43
PDPK1 O15530 1/20 0.43
CCNB2 O95067 1/20 0.43
PRKCB P05771 1/20 0.43
CDK1 P06493 1/20 0.43
LYN P07948 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNA2 P20248 1/20 0.43
CDK2 P24941 1/20 0.43
GSK3B P49841 1/20 0.43
RPS6KA3 P51812 1/20 0.43
CCNA1 P78396 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL4337526 0.92 CA12 (0.47) CA12CA1CA2CA9CYP3A4
Trifluoromethanesulfonic Acid SCHEMBL4337524 0.91 CA1 (0.48) CA12CA1CA2CA9CYP3A4
SCHEMBL30688720 0.84 CA12 (0.49) CA12CA1CA2CA9CYP3A4
SCHEMBL13925821 0.84 SCN9A (0.51) CA12CA1CA2CA9CYP3A4
SCHEMBL30345053 0.82 KDM4E (0.59) CYP3A4KDM4EL3MBTL1MEN1GAA
SCHEMBL30336602 0.82 KDM4E (0.59) CYP3A4KDM4EL3MBTL1MEN1GAA
SCHEMBL25717389 0.82 KDM4E (0.59) CYP3A4KDM4EL3MBTL1MEN1GAA
SCHEMBL30599177 0.80 SCN9A (0.49) CA12CA1CA2CA9CYP3A4
SCHEMBL26251803 0.80 SCN9A (0.49) CA12CA1CA2CA9CYP3A4
SCHEMBL3514820 0.78 MTNR1A (0.61) CA12CA1CA2CA9SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517919-B9 MARKED PEPTIDES HAVING AFFINITY FOR A PHOSPHOLIPID AND USES COMMISSARIAT ENERGIE ATOMIQUE (FR) 2009-09-16 EP disclosed
WO-2009033876-A1 APTAMERS LABELED WITH 18F BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-03-19 WO disclosed
EP-2036981-A1 Aptamers labeled with 18F Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-18 EP disclosed
EP-1517919-B1 MARKED PEPTIDES HAVING AFFINITY FOR A PHOSPHOLIPID AND USES COMMISSARIAT ENERGIE ATOMIQUE (FR) 2009-03-11 EP disclosed
EP-1517903-A2 MARKED MALEIMIDE COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR MARKING MACROMOLECULES COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2005-03-30 EP disclosed
WO-2004002984-A2 MARKED MALEIMIDE COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR MARKING MACROMOLECULES COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2004-01-08 WO disclosed